RLMD
Relmada Therapeutics Inc.
$7.61
$0.00(0.00%)
45
Overall
60
Value
63
Tech
13
Quality
Market Cap
$50.78M
Volume
1.56M
52W Range
$0.24 - $7.51
Target Price
$12.80
EPS Estimates Overview
| Current Quarter | $-0.18 | Next Quarter | $-0.19 |
| Current Year | $-0.72 | Next Year | $-1.18 |
| QoQ Growth | -5.6% | YoY Growth | -63.9% |
| 3Y EPS CAGR | +28.2% | Target Price | $12.80 |
| Consensus | Buy | Upside | +68.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $7.61 | 0% | 1.56M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW